Brief: Cereno Scientific Granted OMPD For CS1 In Rare Disease Pulmonary Arterial Hypertension
03/09/2024 07:08
Sept 3 (Reuters) - Cereno Scientific AB CRNOSb.ST :
* CERENO SCIENTIFIC IS GRANTED ORPHAN MEDICINAL PRODUCT
DESIGNATION IN THE EU FOR CS1 IN RARE DISEASE PULMONARY ARTERIAL
HYPERTENSION
Source text for Eikon: ID:nWkr7LnRb8
Further company coverage: CRNOSb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Expects Up To 15 Activated Sites By 2026 In Epimode Trial
Brief: Cereno Scientific Reports Positive Results From Study
Brief: Cereno Scientific Q2 Net Sales Sek 0
Sweden's Cereno Scientific Q2 net loss widens, hurt by clinical development costs
Brief: Cereno Scientific Q2 Loss After Financial Items SEK 30.5 Mln